306 related articles for article (PubMed ID: 16551288)
21. Dialysis water and fluid purity: more than endotoxin.
Glorieux G; Neirynck N; Veys N; Vanholder R
Nephrol Dial Transplant; 2012 Nov; 27(11):4010-21. PubMed ID: 22844107
[TBL] [Abstract][Full Text] [Related]
22. The quality of dialysate: an integrated approach.
Lonnemann G
Kidney Int Suppl; 2000 Aug; 76():S112-9. PubMed ID: 10936807
[TBL] [Abstract][Full Text] [Related]
23. Short bacterial DNA fragments: detection in dialysate and induction of cytokines.
Schindler R; Beck W; Deppisch R; Aussieker M; Wilde A; Göhl H; Frei U
J Am Soc Nephrol; 2004 Dec; 15(12):3207-14. PubMed ID: 15579524
[TBL] [Abstract][Full Text] [Related]
24. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
25. Conventional versus ultrapure dialysate for lowering serum lipoprotein(a) levels in patients on long-term hemodialysis: a randomized trial.
Tao J; Sun Y; Li X; Li H; Liu S; Wen Y; Duan L; Li Y; Li X
Int J Artif Organs; 2010 May; 33(5):290-6. PubMed ID: 20593350
[TBL] [Abstract][Full Text] [Related]
26. Response of peripheral blood mononuclear cells in hemodialyzed patients against endotoxin and muramyldipeptide.
Nakatani T; Tsuchida K; Sugimura K; Yoshimura R; Takemoto Y
Int J Mol Med; 2002 Oct; 10(4):469-72. PubMed ID: 12239595
[TBL] [Abstract][Full Text] [Related]
27. Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress".
Izuhara Y; Miyata T; Saito K; Ishikawa N; Kakuta T; Nangaku M; Yoshida H; Saito A; Kurokawa K; van Ypersele de Strihou C
Am J Kidney Dis; 2004 Jun; 43(6):1024-9. PubMed ID: 15168382
[TBL] [Abstract][Full Text] [Related]
28. 'Clean dialysate' requires not only lower levels of endotoxin but also sterility of dilution water.
Shinoda T
Blood Purif; 2004; 22 Suppl 2():78-80. PubMed ID: 15655329
[TBL] [Abstract][Full Text] [Related]
29. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
[TBL] [Abstract][Full Text] [Related]
30. [The level of endotoxins in hemodialysis water and dialysate].
Skarupskiene I; Bumblyte IA; Kuzminskis V
Medicina (Kaunas); 2007; 43 Suppl 1():81-4. PubMed ID: 17551282
[TBL] [Abstract][Full Text] [Related]
31. Ultrafiltration and endotoxin removal from dialysis fluids.
Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
[TBL] [Abstract][Full Text] [Related]
32. Assessment of inflow of endotoxin and its fragments in patients on maintenance hemodialysis.
Suzuki H; Honda H; Kato N; Michihata T; Takahashi K; Shishido K; Akizawa T
Blood Purif; 2011; 31(4):268-75. PubMed ID: 21242680
[TBL] [Abstract][Full Text] [Related]
33. Microbiological purity of dialysate for on-line substitution fluid preparation.
Canau B; Bosc JY; Leray H; Stec F
Nephrol Dial Transplant; 2000; 15 Suppl 2():21-30. PubMed ID: 11051034
[TBL] [Abstract][Full Text] [Related]
34. Chronic inflammation in hemodialysis: the role of contaminated dialysate.
Lonnemann G
Blood Purif; 2000; 18(3):214-23. PubMed ID: 10859424
[TBL] [Abstract][Full Text] [Related]
35. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
[No Abstract] [Full Text] [Related]
36. Sterile versus non-sterile dialysis fluid in chronic hemodialysis treatment.
Bambauer R; Meyer S; Jung H; Goehl H; Nystrand R
ASAIO Trans; 1990; 36(3):M317-20. PubMed ID: 2252688
[TBL] [Abstract][Full Text] [Related]
37. When good water goes bad: how it happens, clinical consequences and possible solutions.
Lonnemann G
Blood Purif; 2004; 22(1):124-9. PubMed ID: 14732820
[TBL] [Abstract][Full Text] [Related]
38. The impact of membrane permeability and dialysate purity on cardiovascular outcomes.
Asci G; Tz H; Ozkahya M; Duman S; Demirci MS; Cirit M; Sipahi S; Dheir H; Bozkurt D; Kircelli F; Ok ES; Erten S; Ertilav M; Kose T; Basci A; Raimann JG; Levin NW; Ok E;
J Am Soc Nephrol; 2013 May; 24(6):1014-23. PubMed ID: 23620396
[TBL] [Abstract][Full Text] [Related]
39. [Systemic inflammatory reactions to extracorporeal therapy measures (I): Hemodialysis and hemofiltration].
Schlee H; Prondzinsky R; Osten B; Werdan K
Wien Klin Wochenschr; 1997 May; 109(9):301-11. PubMed ID: 9265388
[TBL] [Abstract][Full Text] [Related]
40. Monitoring the microbial purity of the treated water and dialysate.
Canaud B; Martin K; Morena M; Bosc JY; Leray-Moragues H; Mahowashi M; Stec F; Hansel S
Saudi J Kidney Dis Transpl; 2001; 12(3):325-6. PubMed ID: 18209379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
